Literature DB >> 17185906

A case of ACTH-independent bilateral macronodular adrenal hyperplasia and severe congestive heart failure.

D Suri1, M Alonso, R E Weiss.   

Abstract

Cortisol secretion in ACTH independent bilateral macronodular adrenal hyperplasia (AIMAH) can be regulated by aberrant adrenal receptors. We describe a patient with Cushing's syndrome (CS) due to AIMAH and concomitant Class IV congestive heart failure (CHF). Clinical testing for the presence of aberrant receptors revealed a pronounced serum cortisol (257%) and aldosterone response (212%) to the administration of ACTH and a partial serum cortisol (35%) and aldosterone (106%) response to upright posture. This suggested the possible presence of aberrant hormone receptors for ACTH [melanocortin 2 receptor (MC2-R)], vasopressin, catecholamines or angiotensin II (AT-II) on the patient's adrenal glands. Adrenal tissue from the patient demonstrated an eight-fold increased expression of MC2-R compared to normal adrenal tissue. This increased expression was consistent with the increase in cortisol and aldosterone seen in response to exogenous ACTH. We propose that the severe CHF resulted in activation of the renin-angiotensin system, with an increased production of AT-II. The elevated circulating levels of AT-II may have led to increased expression of MC2-R on the patient's adrenal glands and increased responsiveness to ACTH. This unusual case of CS may elucidate a heretofore unknown mechanism for the development of AIMAH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185906     DOI: 10.1007/BF03349201

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

1.  Circadian variation in Cushing's disease and pseudo-Cushing states by analysis of F and ACTH pulsatility.

Authors:  J M Cunningham; O M Buxton; R E Weiss
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

2.  Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome.

Authors:  A Lacroix; N Ndiaye; J Tremblay; P Hamet
Journal:  Endocr Rev       Date:  2001-02       Impact factor: 19.871

3.  Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation.

Authors:  J M Swain; C S Grant; R T Schlinkert; G B Thompson; J A vanHeerden; R V Lloyd; W F Young
Journal:  Arch Surg       Date:  1998-05

4.  Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II.

Authors:  Y Nakamura; Y Son; Y Kohno; D Shimono; N Kuwamura; H Koshiyama; H Sasano; T Matsuda
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

5.  Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?

Authors:  H Mircescu; J Jilwan; N N'Diaye; I Bourdeau; J Tremblay; P Hamet; A Lacroix
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

6.  Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease.

Authors:  Daesman Suri; Roy E Weiss
Journal:  J Clin Endocrinol Metab       Date:  2004-12-07       Impact factor: 5.958

Review 7.  Cushing's syndrome variants secondary to aberrant hormone receptors.

Authors:  André Lacroix; Valérie Baldacchino; Isabelle Bourdeau; Pavel Hamet; Johanne Tremblay
Journal:  Trends Endocrinol Metab       Date:  2004-10       Impact factor: 12.015

8.  Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II.

Authors:  M C Lebrethon; D Naville; M Begeot; J M Saez
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

9.  The cloning of a family of genes that encode the melanocortin receptors.

Authors:  K G Mountjoy; L S Robbins; M T Mortrud; R D Cone
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

10.  Type 1 angiotensin II receptors of adrenal tumors.

Authors:  H Nawata; R Takayanagi; K Ohnaka; Y Sakai; K Imasaki; T Yanase; S Ikuyama; S Tanaka; K Ohe
Journal:  Steroids       Date:  1995-01       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.